UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...

Screening for familial ovarian cancer: poor survival of BRCA1/2 related cancers

Journal of medical genetics, 2009-09, Vol.46 (9), p.593-597

2009

Link zum Volltext

Verfügbarkeit prüfen

Risk reducing mastectomy: outcomes in 10 European centres

Journal of medical genetics, 2009-04, Vol.46 (4), p.254-258

2009

Link zum Volltext

Verfügbarkeit prüfen

ANO7 is associated with aggressive prostate cancer

International journal of cancer, 2018-11, Vol.143 (10), p.2479-2487

2018

Link zum Volltext

Verfügbarkeit prüfen

Age-specific incidence rates for breast cancer in carriers of BRCA1 mutations from Norway

Clinical genetics, 2013-01, Vol.83 (1), p.88-91

2013

Link zum Volltext

Verfügbarkeit prüfen

Genetic epidemiology of BRCA mutations – family history detects less than 50% of the mutation carriers

European journal of cancer (1990), 2007-07, Vol.43 (11), p.1713-1717

2007

Link zum Volltext

Verfügbarkeit prüfen

Psychological distress in women at risk of hereditary breast/ovarian or HNPCC cancers in the absence of demonstrated mutations

Familial cancer, 2005-06, Vol.4 (2), p.121-126

2005

Link zum Volltext

Verfügbarkeit prüfen

Current clinical criteria for Lynch syndrome are not sensitive enough to identify MSH6 mutation carriers

Journal of medical genetics, 2010-09, Vol.47 (9), p.579-585

2010

Link zum Volltext

Verfügbarkeit prüfen

Author Correction: Large-scale transcriptome-wide association study identifies new prostate cancer risk regions

Nature communications, 2019-01, Vol.10 (1), p.171-171, Article 171

2019

Link zum Volltext

Verfügbarkeit prüfen

Survival in women with MMR mutations and ovarian cancer: a multicentre study in Lynch syndrome kindreds

Journal of medical genetics, 2010-02, Vol.47 (2), p.99-102

2010

Link zum Volltext

Verfügbarkeit prüfen

Lifestyle factors and breast cancer risk in females with PTEN Hamartoma Tumor Syndrome

EUROPEAN JOURNAL OF HUMAN GENETICS, 2024, Vol.32, p.568

2024

Link zum Volltext

Verfügbarkeit prüfen

Prophylactic bilateral salpingo-oophorectomy (PBSO) with or without prophylactic bilateral mastectomy (PBM) or no intervention in BRCA1 mutation carriers. A cost-effectiveness analysis

European journal of cancer supplements, 2008, Vol.6 (7), p.91-91

2008

Link zum Volltext

Verfügbarkeit prüfen

Does the age of breast cancer diagnosis in first-degree relatives impact on the risk of breast cancer in BRCA1 and BRCA2 mutation carriers?

Breast cancer research and treatment, 2015-11, Vol.154 (1), p.163-169

2015

Link zum Volltext

Verfügbarkeit prüfen

Genetic epidemiology of BRCA1 mutations in Norway

European journal of cancer (1990), 2001-12, Vol.37 (18), p.2428-2434

2001

Link zum Volltext

Verfügbarkeit prüfen

Costs and benefits of diagnosing familial breast cancer

Disease markers, 1999-10, Vol.15 (1-3), p.167-173

1999

Link zum Volltext

Verfügbarkeit prüfen

BRCA1 1675delA and 1135insA account for one third of Norwegian familial breast-ovarian cancer and are associated with later disease onset than less frequent mutations

Disease markers, 1999-10, Vol.15 (1-3), p.79-84

1999

Link zum Volltext

Verfügbarkeit prüfen

The Norwegian founder mutations in BRCA1: high penetrance confirmed in an incident cancer series and differences observed in the risk of ovarian cancer

European journal of cancer (1990), 2003-10, Vol.39 (15), p.2205-2213

2003

Link zum Volltext

Verfügbarkeit prüfen

Survival in prospectively ascertained familial breast cancer: Analysis of a series stratified by tumour characteristics, BRCA mutations and oophorectomy

International journal of cancer, 2002-10, Vol.101 (6), p.555-559

2002

Link zum Volltext

Verfügbarkeit prüfen

The role of the prostate cancer gene 3 urine test in addition to serum prostate-specific antigen level in prostate cancer screening among breast cancer, early-onset gene mutation carriers

Urologic oncology, 2015-05, Vol.33 (5), p.202.e19-202.e28

2015

Link zum Volltext

Verfügbarkeit prüfen

Chromosomes 4 and 8 implicated in a genome wide SNP linkage scan of 762 prostate cancer families collected by the ICPCG

The Prostate, 2012-03, Vol.72 (4), p.410-426

2012

Link zum Volltext

Verfügbarkeit prüfen

Genome-wide linkage analysis of 1,233 prostate cancer pedigrees from the International Consortium for prostate cancer Genetics using novel sumLINK and sumLOD analyses

The Prostate, 2010-05, Vol.70 (7), p.735-744

2010

Link zum Volltext

Verfügbarkeit prüfen

A BRCA1 founder mutation, identified with haplotype analysis, allowing genotype/phenotype determination and predictive testing

European journal of cancer (1990), 1997-12, Vol.33 (14), p.2390-2392

1997

Link zum Volltext

Verfügbarkeit prüfen

Effects of n-3 fatty acids during neoplastic progression and comparison of in vitro and in vivo sensitivity of two human tumour cell lines

British journal of cancer, 1995-04, Vol.71 (4), p.691-696

1995

Link zum Volltext

Verfügbarkeit prüfen

Efficacy of early diagnosis and treatment in women with a family history of breast cancer

Disease markers, 1999, Vol.15 (1-3), p.179-186

1999

Link zum Volltext

Verfügbarkeit prüfen

Compelling evidence for a prostate cancer gene at 22q12.3 by the International Consortium for Prostate Cancer Genetics

Human molecular genetics, 2007-06, Vol.16 (11), p.1271-1278

2007

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 106

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(98)
Mit Volltextzugriff
(100)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Screening for familial ovarian cancer: poor survival of BRCA1/2 related cancers

Risk reducing mastectomy: outcomes in 10 European centres

ANO7 is associated with aggressive prostate cancer

Age-specific incidence rates for breast cancer in carriers of BRCA1 mutations from Norway

Genetic epidemiology of BRCA mutations – family history detects less than 50% of the mutation carriers

Psychological distress in women at risk of hereditary breast/ovarian or HNPCC cancers in the absence of demonstrated mutations

Lifestyle Factors and Breast Cancer in Females with PTEN Hamartoma Tumor Syndrome (PHTS)

Current clinical criteria for Lynch syndrome are not sensitive enough to identify MSH6 mutation carriers

Author Correction: Large-scale transcriptome-wide association study identifies new prostate cancer risk regions

Survival in women with MMR mutations and ovarian cancer: a multicentre study in Lynch syndrome kindreds

Lifestyle factors and breast cancer risk in females with PTEN Hamartoma Tumor Syndrome

Prophylactic bilateral salpingo-oophorectomy (PBSO) with or without prophylactic bilateral mastectomy (PBM) or no intervention in BRCA1 mutation carriers. A cost-effectiveness analysis

Does the age of breast cancer diagnosis in first-degree relatives impact on the risk of breast cancer in BRCA1 and BRCA2 mutation carriers?

Genetic epidemiology of BRCA1 mutations in Norway

Costs and benefits of diagnosing familial breast cancer

BRCA1 1675delA and 1135insA account for one third of Norwegian familial breast-ovarian cancer and are associated with later disease onset than less frequent mutations

The Norwegian founder mutations in BRCA1: high penetrance confirmed in an incident cancer series and differences observed in the risk of ovarian cancer

Survival in prospectively ascertained familial breast cancer: Analysis of a series stratified by tumour characteristics, BRCA mutations and oophorectomy

The role of the prostate cancer gene 3 urine test in addition to serum prostate-specific antigen level in prostate cancer screening among breast cancer, early-onset gene mutation carriers

Chromosomes 4 and 8 implicated in a genome wide SNP linkage scan of 762 prostate cancer families collected by the ICPCG

Genome-wide linkage analysis of 1,233 prostate cancer pedigrees from the International Consortium for prostate cancer Genetics using novel sumLINK and sumLOD analyses

A BRCA1 founder mutation, identified with haplotype analysis, allowing genotype/phenotype determination and predictive testing

Effects of n-3 fatty acids during neoplastic progression and comparison of in vitro and in vivo sensitivity of two human tumour cell lines

Efficacy of early diagnosis and treatment in women with a family history of breast cancer

Compelling evidence for a prostate cancer gene at 22q12.3 by the International Consortium for Prostate Cancer Genetics

Suchergebnisse filtern